TEM

Tempus AI, Inc. (NASDAQ:TEM) is a healthcare technology company founded in 2015 and headquartered in Chicago, Illinois. The company was originally incorporated as Tempus Labs, Inc. before changing its name to Tempus AI, Inc. in January 2023 to reflect its focus on artificial intelligence applications in healthcare. Tempus operates as a precision medicine platform that combines genomic testing, clinical data analytics, and AI-powered insights to advance cancer care and treatment decisions. The company went public in 2012 and has grown through strategic acquisitions and partnerships to become a significant player in the molecular diagnostics and healthcare data analytics space.